drug company novartis has been accused of trying to block trials aimed at promoting a â cheap , safe and effective â treatment for sight loss which would save the nhs around Â£ 102million a year avastin is much cheaper and it is estimated that widespread use of the drug would save the nhs around Â£ 102million a year
the bmj obtained emails under a freedom of information request showing that clinicians with ties to novartis had urged some primary care trusts to pull out of one avastin trial , while efforts were made to â derail â a second publicly funded britons trial
the bmj says drug company novartis ( pictured ) has consistently tried to â undermine and divert attention â from trials to prove avastin works â even turning to the rnib for help dr foss said : â he stated novartis would do everything to stop the trial and challenge its ethics